The people and research behind the Angie Project.
The Angie Project brings together researchers, engineers, and academic collaborators working across biomedical engineering, robotics, materials science, and precision medicine.
Its recent peer-reviewed publication in Science marks an important milestone in a broader, long-term effort focused on controlled therapeutic delivery and precision medicine.
Built through long-term research in targeted drug delivery
The Angie Project is built on more than two decades of research spanning biomedical engineering, microrobotics, targeted drug delivery, materials science, and clinical translation. Its recent peer-reviewed publication in Science marks an important milestone in a broader, long-term effort focused on controlled therapeutic delivery and precision medicine.
The project sits at the intersection of scientific research, engineering, and translational medicine, where credibility is built on evidence, repetition, and long-term validation.
A long-term research effort
The Angie Project is the result of more than two decades of scientific development spanning microrobotics, biomedical engineering, and translational medicine.
LOREM IPSUM
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
LOREM IPSUM
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
LOREM IPSUM
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
The people behind the Angie Project
The project combines long-term scientific research with a multidisciplinary and translational approach to targeted drug delivery and precision medicine.
Core team
Researchers and engineers working across biomedical engineering, medical robotics, and materials science at ETH Zürich.
Postdoctoral Researcher
Fabian Landers · Biomedical Engineering · ETH Zürich
PhD Researcher
Vitaly Pustovalov · Biomedical Engineering · ETH Zürich
Medical Robotics
Derick Sivakumaran · Angie Project · ETH Zürich
Postdoctoral Researcher
Cagatay Mert Oral · ETH Zürich
Scientific advisors
Senior researchers providing scientific direction and long-term guidance for the Angie Project at ETH Zürich.
Professor
Brad Nelson · ETH Zürich
Professor
Salvador Pané Vidal · ETH Zürich
Questions about the Angie Project
The ANGIE Project is a clinically oriented targeted drug-delivery platform designed to support controlled navigation and localised therapeutic release within complex vascular environments.
Built on more than two decades of research across biomedical engineering, medical robotics, materials science, and precision medicine, the project explores new approaches to delivering therapies more precisely within the body.
The Angie Project builds upon more than 20 years of research conducted at ETH Zürich and through international scientific collaborations.
The field has been shaped by pioneering contributions from researchers including Prof. Brad Nelson and Prof. Salvador Pané Vidal, whose work has helped advance medical microrobotics, magnetic navigation, and targeted therapeutic delivery.
Today, the project is carried forward by a multidisciplinary team of researchers and engineers working across biomedical engineering, robotics, materials science, and precision medicine.
Recent publications and media coverage have highlighted important developments within the project, including peer-reviewed research published in Science.
However, these milestones represent one stage in a much longer scientific journey built on decades of research, experimentation, and technological development.
Scientific progress often becomes visible at key moments, while the underlying work spans many years.
Precision medicine seeks to tailor treatments to individual patients and specific disease characteristics.
The Angie Project contributes to this broader vision by exploring how therapies might be delivered more precisely, supporting localized treatment approaches and reducing unnecessary systemic exposure.
The project continues to advance through ongoing research, engineering development, scientific validation, and cross-disciplinary collaboration.
The long-term objective is to further develop targeted drug-delivery technologies and support their progression toward clinically relevant applications while maintaining a strong commitment to scientific rigour, safety, and transparency.
Following the next steps in targeted drug delivery research.
Magnetically steerable wireless nanodevices for the targeted delivery of therapeutic agents in any vascular region of the body.